TRX Stock Price, Chart, Stats & News

Tissue Regenix Group plc
Save
Tissue Regenix Group plc (TRX) does not currently pay a dividend.
5.16M
Market cap
–
Current P/E
112.36x
Forward P/E
TRX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Tissue Regenix Group plc, established in 2006 and headquartered in Garforth, United Kingdom, is a medical technology enterprise dedicated to advancing the fields of tissue engineering and regenerative medicine. Operating across the United States and international markets, the company develops and commercializes sophisticated platform technologies. Its operations are organized into BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions.
Similar securities
Based on sector and market capitalization
Report issue





